English
Français
Deutsch
Italiano
Português
- Autor:
- Eduardo Anitua
- Gorka Orive
- Sabino Padilla
- Sánchez M
- Fiz N
- Azofra J
- Usabiaga J
- Aduriz Recalde E
- Garcia Gutierrez A
- Albillos J
- Gárate R
- Aguirre JJ
A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis
Arthroscopy. 2012 Aug;28(8):1070-8. This multicenter, double-blind clinical trial evaluated and compared the efficacy and safety of PRGF-Endoret (BTI Biotechnology Institute, Vitoria-Gasteiz, Spain), an autologous biological therapy for regenerative purposes, versus hyaluronic acid (HA) as a short-term treatment for knee pain from osteoarthritis.
- Autor:
- López-Plandolit S
- Morales MC
- Freire V
- Grau AE
- Durán JA.
Efficacy of plasma rich in growth factors for the treatment of dry eye
Cornea. 2011 Dec;30(12):1312-7. To evaluate the efficacy of plasma rich in growth factors (PRGF) for the treatment of moderate/severe dry eye.
- Autor:
- Eduardo Anitua
- Gorka Orive
- Mikel Sánchez
- Rosa Sarabia
- Julian Sanz
- José Javier Aguirre
- Autor:
- López-Plandolit S
- Morales MC
- Freire V
- Etxebarría J
- Durán JA.
Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects
Cornea. 2010 Aug;29(8):843-8. To evaluate the efficacy of topically applied autologous plasma rich in growth factors (PRGF) as a treatment for persistent epithelial defects (PEDs) of the cornea.